Organization - Additional Information (Detail)	Jun. 30, 2012
Novavax, Inc
Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]
Joint venture ownership interest percentage	20.00%
Cadila Pharmaceuticals Limited
Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]
Joint venture ownership interest percentage	80.00%